SR one
SR one
Applying Insight Creating Value.
Investment Fund Manager | United Kingdom of Great Britain and Northern Irela | Access to Information
Overview
SR One is the corporate venture capital arm of GlaxoSmithKline. The firm invests globally in emerging life science companies that are pursuing innovative science which will significantly impact medical care.We have a team of investment professionals located in the US and UK. As a Team our experience spans basic science industry and the market. We take an active role in our portfolio companies and work with management teams and our fellow venture investors to create significant value.Our current portfolio includes approximately 35 private and public companies and since our founding in 1985 we have invested over $830MM in the biotech space.Our expanded remit also focuses on maximizing the value of GSK technological innovation to establish new businesses and revenue opportunities across a range of industries.
Investor Type |
Legal Structure |
Operating Status |
Members |
Investment Fund Manager | Partnership | Operating |
Portfolio
Sep, 2012
Joint Series C + Equity PRI
Genocea Biosciences
Harnessing the power of T cells.
Genocea finds targets of T cell responses to discover and...
sector
Health Improvement
Disease Specific Prevention and Mitigation
Access to Information
regions
Global
People
Investors / Funders
Team
Funds
Impact
Social Objectives:
Environmental Objectives:
Operational Impact:
Impact Reports & Metrics
Offices
Headquarters :
One Broadway
Cambridge
Massachusetts 02142
United States of America